Ruiz Ojeda, F.J. ; Wang, J. ; Bäcker, T. ; Krueger, M.* ; Zamani, S. ; Rosowski, S. ; Gruber, T. ; Onogi, Y. ; Feuchtinger, A. ; Schulz, T.J.* ; Fässler, R.* ; Müller, T.D. ; García-Cáceres, C. ; Meier, M. ; Blüher, M. ; Ussar, S.
Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis.
Mol. Metab. 45:101147 (2021)
Objective: Reorganization of the extracellular matrix is a prerequisite for healthy adipose tissue expansion, whereas fibrosis is a key feature of adipose dysfunction and inflammation. However, very little is known about the direct effects of impaired cell–matrix interaction in adipocyte function and insulin sensitivity. The objective of this study was to determine whether integrin activity can regulate insulin sensitivity in adipocytes and thereby systemic metabolism. Methods: We characterized integrin activity in adipose tissue and its consequences on whole-body metabolism using adipose-selective deletion of β1 integrin (Itgb1adipo-cre) and Kindlin-2 (Kind2adipo-cre) in mice. Results: We demonstrate that integrin signaling regulates white adipocyte insulin action and systemic metabolism. Consequently, loss of adipose integrin activity, similar to loss of adipose insulin receptors, results in a lipodystrophy-like phenotype and systemic insulin resistance. However, brown adipose tissue of Kind2adipo-cre and Itgb1adipo-cre mice is chronically hyperactivated and has increased substrate delivery, reduced endothelial basement membrane thickness, and increased endothelial vesicular transport. Conclusions: Thus, we establish integrin-extracellular matrix interactions as key regulators of white and brown adipose tissue function and whole-body metabolism.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Adipose Tissue ; Brown Fat ; Insulin Receptor ; Insulin Resistance ; Integrins ; Kindlin-2 ; Lipodystrophy ; Obesity
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
2212-8778
e-ISSN
2212-8778
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 45,
Heft: ,
Seiten: ,
Artikelnummer: 101147
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
Amsterdam
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
30204 - Cell Programming and Repair
30505 - New Technologies for Biomedical Discoveries
30205 - Bioengineering and Digital Health
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
Genetics and Epidemiology
Pioneer Campus
Enabling and Novel Technologies
PSP-Element(e)
G-502296-001
G-502200-001
G-500591-001
G-500500-001
G-510002-001
A-630600-001
G-500390-001
G-501900-224
G-506501-001
Förderungen
European Research Council ERC
Deutsche Forschungsgemeinschaft
Fundación Alfonso Martín Escudero
Copyright
Erfassungsdatum
2021-03-26